Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02174250 · ClinicalTrials.gov registry record · Phase 1
The Effect of Rifampin on the Metabolism of Istradefylline in Healthy Volunteers.
A Phase 1 study, sponsored by Kyowa Kirin Co..
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT02174250: Completed Phase 1 study, sponsored by Kyowa Kirin Co..
NCT02174250 is a Phase 1 study that has completed, run by Kyowa Kirin Co.. The registered enrollment target is 20 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (67% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02174250, a Phase 1 study, has completed, sponsored by Kyowa Kirin Co..
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to test whether Rifampin affects blood levels of istradefylline in humans. Rifampin could possibly decrease istradefylline levels.
Interventions
- DRUG Istradefylline 40 mg
- DRUG Rifampin 300mg BID + istradefylline 40mg Day 8 only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2014-06 |
| Est. Completion | 2014-12 |
| Phase | Phase 1 |
What the finished NCT02174250 record still lists
NCT02174250 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (67% lower).
The record links to 0 conditions, and to 2 interventions - of which Istradefylline 40 mg is the first listed.
NCT02174250 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02174250 about?
NCT02174250 is a clinical study titled "The Effect of Rifampin on the Metabolism of Istradefylline in Healthy Volunteers.". The purpose of this study is to test whether Rifampin affects blood levels of istradefylline in humans. Rifampin could possibly decrease istradefylline levels.
What is the current status of trial NCT02174250?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2014-06. Estimated completion is 2014-12.
What interventions are being tested in trial NCT02174250?
The interventions under investigation include: Istradefylline 40 mg (DRUG), Rifampin 300mg BID + istradefylline 40mg Day 8 only (DRUG).
Who is sponsoring clinical trial NCT02174250?
This trial is sponsored by Kyowa Kirin Co., which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02174250's enrollment target sits among peer trials
20 1629th of 2000 higher than 285 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia